Giampaolo Trevisan, Lerica Germi, & Luigi Naldi. (2022). Erythrodermic psoriasis improved by tildrakzumab: A case report. PAGEPress Publications.
Chicago Style (17th ed.) CitationGiampaolo Trevisan, Lerica Germi, and Luigi Naldi. Erythrodermic Psoriasis Improved by Tildrakzumab: A Case Report. PAGEPress Publications, 2022.
MLA (9th ed.) CitationGiampaolo Trevisan, et al. Erythrodermic Psoriasis Improved by Tildrakzumab: A Case Report. PAGEPress Publications, 2022.
Warning: These citations may not always be 100% accurate.